Experience

• 

  Кафедра клинической и социальной гериатрии

  Nov 2009 - Mar 2014

  Laboratory head

  • Management of center with high screening capabilities (patient database – 3500 people)• Design of internal forms of source documentation according to the data required in the protocol• Data input in eCRF; • SAE and AE reporting according to protocol requirements• Query management• Review and control of source documentation prepared by investigators (exclude systematic errors)• Scheduling and executing preparation process for audits (3 internal audits from headquarters)• Representing research center during audits (acquaintance with laboratory, internal procedures of patient management, pre-screening and screening process) Show less

• 

  Оао "издательство "медицина"

  Nov 2012 - Nov 2014

  Переводчик
• 

  Институт непрерывного медицинского образования и социально-демографических исследований рудн

  May 2014 - Nov 2015

  Chief of comparative law department

  * Coordination on the implementation of state projects under Ministry of Education of the Russian Federation* Paritipation in international educational grants* Preparation on and coordination of international educational programs in the field of health management* Educational and methodical work in organizational and legal research of health regulation area* Interaction with the WHO headquarters, the Department of International Cooperation of the Ministry of Health of Russia, the Health Department of JSCo «Russian Railways Show less

• 

  Novartis oncology

  Nov 2015 - Aug 2022

  * Elaboration, management and update of Market Access strategies for Novartis Onco portfolio;* Analysis of legal amendments related to reimbursement and healthcare regulation; * Prepare documents for inclusion of Novartis Hemo brands in federal reimbursement programs (EDL, ONLS, 7N, regional reimbursement lists, OMI Tariffs (DRGs);* Development of stakeholder plans with regional and federal decision makers (government and territory fund of obligatory medical insurance officials, healthcare authorities, federal and regional KOLs) to expand market access for Novartis Onco brands;* Internal conceptual approval and alignment of innovative pricing models/managed entry agreement, external risk mitigation, communication with regional governments on implementation, submission of results to Federal government*Cooperation with Government relations Department on policy-shaping projects to amend existing legal frame of oncology care* Provision of methodological support and training for KAMs, MSLs and regional market managers on MA projects, HEOR and changes in reimbursement and regulatory environment;* Consistent stakeholder engagement and raising payer’s awareness by multidisciplinary educational programs (medical, legal, HEOR) for healthcare authorities on federal and regional level in collaboration with KAMs;* Communication of any data that may impact reimbursement activities on federal and regional level and coordination of further Market Access activities on cross-functional basis (marketing – medical – market access);* Analysis of main gaps in current model of oncology drug provision and implementation of Patient Access * Models to bridge those gaps and overcome the main hurdles that hold down business growth. Show less

  • Head of Market Access

    Jun 2019 - Aug 2022

  • Head of reimbursement and pricing. Market Access

    Feb 2018 - Jun 2019

  • Market access manager

    Sept 2016 - Feb 2018

  • Health economics and outcomes research manager

    Nov 2015 - Sept 2016
• 

  Novartis

  Sept 2022 - now

  Head of value&access innovative medicines russia